Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection

Bone Marrow Transplantation volume 41, pages 39–43 (2008)Cite this article

Abstract

Following initial graft rejection, a second attempt at allogeneic immunotherapy is often contemplated, but data on the success is limited. We therefore report on 11 patients with hematologic malignancies, renal cell cancer or marrow failure who underwent a second reduced-intensity regimen for primary or secondary graft failure. Nine of the 11 patients initially engrafted with the second attempt including two of four who used the same donor. One of the patients engrafted after the third attempt using a different donor and conditioning regimen. There were two treatment-related deaths. Four patients died from progressive disease 1–9 months after the second transplant. Two patients are still in recovery phase less than 1 year from the second transplant. Long-term remission is possible and three patients are alive in complete remission.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McSweeney P, Niederwieser D, Shizuru J, Sandmaier B, Molina A, Maloney D et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.

    Article  CAS  PubMed  Google Scholar 

  2. Barrett AJ, Savani BN . Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia 2006; 20: 1661–1672.

    Article  CAS  PubMed  Google Scholar 

  3. Narimatsu H, Kami M, Miyakoshi S, Murashige N, Yuji K, Hamaki T et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006; 132: 36–41.

    Article  PubMed  Google Scholar 

  4. Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18–29.

    Article  CAS  PubMed  Google Scholar 

  5. Rizzieri DA, Koh LP, Long GD, Gasparetto C, Sullivan KM, Horwitz M et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 2007; 25: 690–697.

    Article  CAS  PubMed  Google Scholar 

  6. Rizzieri DA, Koh LP, Long GD, Gasparetto C, Gong JZ, Lagoo A et al. Outcome and immune reconstitution following T cell depleted nonmyeloablative allogeneic transplantation using matched donors. Blood 2005; 106 (suppl): 2036, Abstract.

    Google Scholar 

  7. http://ctep.cancer.gov/forms/ctcaev3to2.pdf.

  8. Laughlin M, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  9. Fielding A, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 2007; 109: 944–950.

    Article  CAS  PubMed  Google Scholar 

  10. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579–586.

    Article  PubMed  Google Scholar 

  11. Quinones RR . Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol 1993; 15: 3–17.

    Article  CAS  PubMed  Google Scholar 

  12. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204.

    Article  CAS  PubMed  Google Scholar 

  13. Bunjes D, Heit W, Arnold R, Schmeiser T, Wiesneth M, Carbonell F et al. Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 1987; 43: 501–505.

    Article  CAS  PubMed  Google Scholar 

  14. Walshe J, Bishop MR . Factors affecting engraftment of allogeneic hematopoietic stem cells after reduced-intensity conditioning. Cytotherapy 2004; 6: 589–602.

    Article  CAS  PubMed  Google Scholar 

  15. Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ et al. Marrow transplantation for aplastic anemia. Semin Hematol 1984; 21: 27–35.

    CAS  PubMed  Google Scholar 

  16. Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C et al. Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. Br J Haematol 2004; 126: 837–843.

    Article  PubMed  Google Scholar 

  17. Baron F, Sandmaier BM . Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia 2006; 20: 1690–1700.

    Article  CAS  PubMed  Google Scholar 

  18. Hows JM . Mechanisms of graft failure after human marrow transplantation: a review. Immunol Lett 1991; 29: 77–80.

    Article  CAS  PubMed  Google Scholar 

  19. Ruiz-Arguelles GJ, Gomez-Almaguer D, Tarin-Arzaga LD, Morales-Toquero A, Cantu-Rodriguez OG, Manzano C . Second allogeneic peripheral blood stem cell transplants with reduced-intensity conditioning. Rev Invest Clin 2006; 58: 34–38.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Stem Cell Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA

    B J Byrne, M Horwitz, G D Long, C Gasparetto, K M Sullivan, J Chute, N J Chao & D A Rizzieri

Authors
  1. B J Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Horwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G D Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Gasparetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K M Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Chute
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N J Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D A Rizzieri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D A Rizzieri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Byrne, B., Horwitz, M., Long, G. et al. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant 41, 39–43 (2008). https://doi.org/10.1038/sj.bmt.1705882

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705882

Keywords

This article is cited by

Search

Advanced search

Quick links